which suggested that fibrinogen did not enter a depletion state. Fibrinogen has been proven to be a biological marker of the severity of pneumonia, and its increase is one of the manifestations of SARS-CoV-2-induced inflammation26,27. In addition...
First imported case of 2019 novel coronavirus in Canada, presenting as mild pneumoniadoi:10.1016/S0140-6736(20)30370-6William Kyle SilversteinLynfa StroudGraham Edward CleghornJerome Allen LeisThe Lancet
Clinicians define mild pneumonia as patients who are "not too sick," have normal respiratory and mental status, and are able to maintain oral intake. As yet there is no uniform definition of mild pneumonia. By inference, mild pneumonia occurs in younger patients with less comorbidity and has ...
For the GV-971 group, the SAE of infectious pneumonia reported by one participant was determined as being possibly related to the trial drug by investigators. The remaining SAEs were determined to be not related or possibly related to the trial drug. Tables S1-1 and S1-2 in the ...
3. No imaging findings of pneumonia. All patients between the ages of 18 to 65 years, suited to the aforementioned inclusion criteria who consented to participate were enlisted in an electronic patient record, along with their demographic and admission details. The patients were invited for a tele...
Signs and symptoms of COVID-19 vary, ranging from mild respiratory tract illness similar to flu-like infections, to severe progressive pneumonia, multiorgan failure, and death. Common symptoms include fever, persistent dry cough, fatigue, shortness of breath, body ache, headache, loss of smell ...
The rapid spread of SARS-CoV-2 across continents triggered WHO to declare the COVID-19 outbreak a pandemic in March, 2020. The clinical manifestations of COVID-19 range from asymptomatic infection to severe viral pneumonia with potentially lethal respiratory failure. The progression to severe ...
Treatment with LHQW did not accelerate the negative conversion of NAAT findings (10.5 vs. 14.0 days, HR: 1.12, 95% CI 0.94–1.34) (Fig. 4). Only 15 patients in LHQW group and 9 in placebo group had radiologic evidence of pneumonia at baseline, and the rate of chest imaging improvement...
Two of the deaths were classified as due to COVID-19 pneumonia, 1 as pneumonia, and 1 as respiratory failure. Serious adverse events and grade 3 or 4 adverse events were less common in patients receiving sotrovimab compared with placebo. No serious adverse events were considered related to ...
He died before 1 year of age from pneumonia, at which time his weight was 3000 g. His eldest brother, who died at 5 months of age with leukocytosis and proteinuria, had similar features: intrauterine growth retardation, microcephaly, bilateral microphthalmia, failure to thrive, progressive ...